HOME › DRUGS › ZANUBRUTINIB
ACTIVE SUBSTANCE / INN

ZANUBRUTINIB

Brand name(s): Brukinsa, BRUKINSA
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA218785
Waldenstrom Macroglobulinemia
ACTIVE SUBSTANCE
Zanubrutinib
REGULATORS
FDA · EMA
SPONSORS / MAH
BeOne Medicines Ireland Limited, BEONE MEDICINES USA
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BRUKINSANDA213217BEONE MEDICINES USADiscontinued
BRUKINSANDA218785BEONE MEDICINES USAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BrukinsaBeOne Medicines Ireland LimitedAuthorised22/11/2021Waldenstrom Macroglobulinemia

FULL INTELLIGENCE ON ZANUBRUTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →